Prolastin is a commercially available form of alpha-1-antitrypsin (AAT) that is derived from pooled human plasma and used for treatment of severe alpha-1-antitrypsin deficiency (AATD). This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.